Ikuya Shiromizu

Title: Ikuya Shiromizu: Innovator in Pharmaceutical Chemistry

Introduction

Ikuya Shiromizu is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative drug compounds. With a focus on anticoagulation agents, his work has the potential to impact medical treatments significantly.

Latest Patents

Ikuya Shiromizu holds 2 patents related to tricyclic compounds. His latest invention involves a tricyclic compound having a spiro union, which is represented by a specific formula. This compound is particularly useful as a drug, serving as an inhibitor for activated blood coagulation factor X. It can be administered orally and exhibits strong anticoagulation action. Additionally, the invention includes a pharmacophore derived from the compound, which is beneficial in the molecular design of FXa inhibitors.

Career Highlights

Ikuya Shiromizu is associated with Mochida Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work in the pharmaceutical industry has positioned him as a key figure in the innovation of new therapeutic agents.

Collaborations

Some of his notable coworkers include Hidemitsu Nishida and Fumihiko Saitoh, who collaborate with him on various projects within the company.

Conclusion

Ikuya Shiromizu's contributions to pharmaceutical chemistry, particularly through his innovative patents, highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in drug development and therapeutic applications.